A carregar...
P15.01 WOUND HEALING COMPLICATIONS IN BRAIN TUMOR PATIENTS ON BEVACIZUMAB
Bevacizumab (BV) is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A) and is commonly used for treatment of recurrent glioblastoma (GBM). Wound healing problems are a well-established adverse event, which may be compounded by the concomitant use of corticosteroids. Here, we...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185639/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.280 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|